HCA Healthcare, Inc. (HCA) stock
HCANYSEServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/302% below fair value
$511.78+12.73 (+2.55%)
Close on Nov 16, 2026Market cap $106.91BP/E 17.0Yield 0.56%
HCA Healthcare total assets
Total assets on the balance sheet at the end of each period.
HCA Healthcare's total assets was $63.45B at Sep 30, 2026. For fiscal 2025 it was $60.72B, up 2.0% from the year before. Over ten years it grew 6.4% a year on average. The highest annual figure on record is $60.72B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $60.72B | +2.0% |
| FY2024 | Dec 31, 2024 | $59.51B | +5.9% |
| FY2023 | Dec 31, 2023 | $56.21B | +7.2% |
| FY2022 | Dec 31, 2022 | $52.44B | +3.3% |
| FY2021 | Dec 31, 2021 | $50.74B | +6.8% |
| FY2020 | Dec 31, 2020 | $47.49B | +5.4% |
| FY2019 | Dec 31, 2019 | $45.06B | +14.9% |
| FY2018 | Dec 31, 2018 | $39.21B | +7.1% |
| FY2017 | Dec 31, 2017 | $36.59B | +8.4% |
| FY2016 | Dec 31, 2016 | $33.76B | +3.1% |
| FY2015 | Dec 31, 2015 | $32.74B | +5.7% |
| FY2014 | Dec 31, 2014 | $30.98B | +8.3% |
| FY2013 | Dec 31, 2013 | $28.59B | +1.8% |
| FY2012 | Dec 31, 2012 | $28.08B | +4.4% |
| FY2011 | Dec 31, 2011 | $26.90B | +12.8% |
| FY2010 | Dec 31, 2010 | $23.85B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $63.45B | +6.2% |
| Q2 FY2026 | Jun 30, 2026 | $63.25B | +6.2% |
| Q1 FY2026 | Mar 31, 2026 | $61.45B | +2.8% |
| Q4 FY2025 | Dec 31, 2025 | $60.72B | +2.0% |
| Q3 FY2025 | Sep 30, 2025 | $59.75B | +0.5% |
| Q2 FY2025 | Jun 30, 2025 | $59.54B | +3.8% |
| Q1 FY2025 | Mar 31, 2025 | $59.80B | +5.0% |
| Q4 FY2024 | Dec 31, 2024 | $59.51B | +5.9% |
| Q3 FY2024 | Sep 30, 2024 | $59.46B | +8.9% |
| Q2 FY2024 | Jun 30, 2024 | $57.38B | +7.1% |
| Q1 FY2024 | Mar 31, 2024 | $56.96B | +8.1% |
| Q4 FY2023 | Dec 31, 2023 | $56.21B | +7.2% |
| Q3 FY2023 | Sep 30, 2023 | $54.59B | +6.0% |
| Q2 FY2023 | Jun 30, 2023 | $53.59B | +3.9% |
| Q1 FY2023 | Mar 31, 2023 | $52.71B | +1.0% |
| Q4 FY2022 | Dec 31, 2022 | $52.44B | +3.3% |
| Q3 FY2022 | Sep 30, 2022 | $51.48B | +3.9% |
| Q2 FY2022 | Jun 30, 2022 | $51.58B | +7.1% |
| Q1 FY2022 | Mar 31, 2022 | $52.21B | +10.4% |
| Q4 FY2021 | Dec 31, 2021 | $50.74B | +6.8% |
| Q3 FY2021 | Sep 30, 2021 | $49.56B | -2.9% |
| Q2 FY2021 | Jun 30, 2021 | $48.16B | -1.1% |
| Q1 FY2021 | Mar 31, 2021 | $47.28B | +4.1% |
| Q4 FY2020 | Dec 31, 2020 | $47.49B | +5.4% |
| Q3 FY2020 | Sep 30, 2020 | $51.02B | +16.2% |
| Q2 FY2020 | Jun 30, 2020 | $48.71B | +7.2% |
| Q1 FY2020 | Mar 31, 2020 | $45.42B | +4.7% |
| Q4 FY2019 | Dec 31, 2019 | $45.06B | +14.9% |
| Q3 FY2019 | Sep 30, 2019 | $43.91B | +15.4% |
| Q2 FY2019 | Jun 30, 2019 | $45.45B | +20.4% |
| Q1 FY2019 | Mar 31, 2019 | $43.38B | +16.3% |
| Q4 FY2018 | Dec 31, 2018 | $39.21B | +7.1% |
| Q3 FY2018 | Sep 30, 2018 | $38.04B | +6.5% |
| Q2 FY2018 | Jun 30, 2018 | $37.74B | +9.2% |
| Q1 FY2018 | Mar 31, 2018 | $37.30B | +10.4% |
| Q4 FY2017 | Dec 31, 2017 | $36.59B | +8.4% |
| Q3 FY2017 | Sep 30, 2017 | $35.73B | – |
| Q2 FY2017 | Jun 30, 2017 | $34.57B | – |
| Q1 FY2017 | Mar 31, 2017 | $33.80B | – |
| Q4 FY2016 | Dec 31, 2016 | $33.76B | – |
See a number that looks wrong?